Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Ranibizumab × Clear all

NCT00657202 2016-07-07

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Phase EARLY_PHASE1 Completed

Neurofibroma, Neurofibromatosis 1